EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Personalizing Obesity Treatment: Real-World Comparison of a Very-Low-Calorie Ketogenic Diet Versus a Whole-Food Mediterranean Ketogenic Diet

Davide Masi iD, Maria Letizia Spizzichini, Elena Colonnello iD, Daniel Vasquez Barahona, Lucio Gnessi iD, Daniele Gianfrilli iD, Mikiko Watanabe iD

Metabolites · 05.04.2026 · 16 (4) · 248

DOI: 10.3390/metabo16040248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 05.04.2026. Verfasst von Davide Masi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, 00161 Rome, Ita…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8-Project Age-It: "Ageing Well in an Ageing Society". This resour….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Obesity is a chronic, relapsing disease in which lifestyle modification represents the cornerstone of treatment. Among dietary strategies, ketogenic diets can induce rapid weight loss, whereas the Mediterranean diet is associated with established cardiometabolic benefits but typically produces slower weight reduction. Very-low-calorie ketogenic diets (VLCKDs) are effective for weight loss but are often limited by cost, reliance on meal replacements, and reduced long-term feasibility. This study aimed to evaluate whether a whole-food Mediterranean ketogenic diet with moderate caloric restriction (MedKD) could represent a feasible and effective alternative to VLCKD for weight loss and metabolic improvement in adults with obesity.

Methods

This 3-month prospective, real-world study compared VLCKD and MedKD in adults with obesity attending a clinical nutrition program. The primary outcome was percentage weight loss. Secondary outcomes included changes in waist circumference, waist-to-height ratio, insulin resistance (HOMA-IR), lipid profile, kidney function, and treatment tolerability. Clinical and biochemical parameters were assessed at baseline and after the intervention. Group differences and time-by-group interactions were analyzed to evaluate changes over the study period.

Results

Sixty-two participants were enrolled, and 55 completed the study (27 VLCKD, 28 MedKD). Baseline characteristics were generally comparable, although the MedKD group had a higher prevalence of diabetes and higher baseline insulin resistance and triglyceride levels. Both dietary interventions resulted in substantial and comparable weight loss (approximately 15% of initial body weight), accompanied by significant reductions in waist circumference and waist-to-height ratio. Insulin resistance improved in both groups, with a greater reduction in HOMA-IR observed in the MedKD group (time × group p = 0.031). Serum creatinine decreased in the VLCKD group and slightly increased in the MedKD group (p = 0.025). Changes in lipid profile were not significantly different between groups. No severe adverse events were reported.

Conclusions

A whole-food Mediterranean ketogenic diet with moderate caloric restriction achieved weight loss and metabolic improvements comparable to those observed with VLCKD over three months. These findings suggest that MedKD may represent a feasible alternative to formula-based ketogenic programs, supporting more flexible and personalized dietary strategies in the clinical management of obesity.

Schlagwörter

Stichwörter der Autor:innen

Mediterranean dietMediterranean ketogenic dietinsulin resistanceketogenic dietlifestyle interventionobesitypersonalized nutritionvery-low-calorie ketogenic dietweight loss

Autor:innen und Institutionen

  • Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, 00161 Rome, Italy.
  • Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • UOC of Otorhinolaryngology, Department of Medical Sciences, Giuliano Isontina Medical Institution, Cattinara Hospital, 34149 Trieste, Italy.

ORCID-Profile: Davide Masi, Elena Colonnello, Lucio Gnessi, Daniele Gianfrilli, Mikiko Watanabe

Förderung

  • Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8-Project Age-It: "Ageing Well in an Ageing Society". This resour…

Zitieren

APA

Masi, D., Spizzichini, M. L., Colonnello, E., Vasquez Barahona, D., Gnessi, L., Gianfrilli, D., & Watanabe, M. (2026). Personalizing Obesity Treatment: Real-World Comparison of a Very-Low-Calorie Ketogenic Diet Versus a Whole-Food Mediterranean Ketogenic Diet. Metabolites, 16(4), 248. https://doi.org/10.3390/metabo16040248

Vancouver

Masi D, Spizzichini ML, Colonnello E, Vasquez Barahona D, Gnessi L, Gianfrilli D, et al. Personalizing Obesity Treatment: Real-World Comparison of a Very-Low-Calorie Ketogenic Diet Versus a Whole-Food Mediterranean Ketogenic Diet. Metabolites. 2026;16(4):248. doi:10.3390/metabo16040248

BibTeX
@article{Masi2026,
  author = {Masi, Davide and Spizzichini, Maria Letizia and Colonnello, Elena and Vasquez Barahona, Daniel and Gnessi, Lucio and Gianfrilli, Daniele and Watanabe, Mikiko},
  title = {Personalizing Obesity Treatment: Real-World Comparison of a Very-Low-Calorie Ketogenic Diet Versus a Whole-Food Mediterranean Ketogenic Diet},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {248},
  doi = {10.3390/metabo16040248}
}
Kostenlos starten →